Inhibition of Tumor Necrosis Factor-induced Necrotic Cell Death by the Zinc Finger Protein A20
Overview
Authors
Affiliations
Tumor Necrosis Factor (TNF) is a cytokine that induces necrotic and apoptotic forms of cell death. The TNF-induced signalling mechanisms leading to necrosis or apoptosis are partially distinct, and are therefore likely to be regulated in a different way. The zinc finger protein A20 is a TNF-induced primary response gene that has been shown to inhibit TNF-induced apoptosis. However, its ability to inhibit the necrotic route of cell death as well as the underlying mechanism remains unknown. Here we show that stable expression of A20 or a fusion protein consisting of Green Fluorescent Protein (GFP) and A20 protects the TNF-sensitive fibroblast cell line L929 partially from TNF-induced necrotic cell death. TNF-induced necrosis has been shown to involve the activation of several phospholipases, as well as an increased production of reactive oxygen radicals. The reduced TNF-sensitivity of A20-expressing L929 cells was correlated with a decrease of TNF-induced phospholipase A2 (PLA2), phospholipase C (PLC) and phospholipase D (PLD) activation. Furthermore, production of mitochondrial reactive oxygen intermediates was retarded by overexpression of A20. These results demonstrate that A20 not only inhibits TNF-induced apoptosis but also TNF-induced necrosis, suggesting that it interferes with an early step in TNF signalling which is required for both types of cell death.
Dynamic post-translational modification profiling of -infected primary macrophages.
Budzik J, Swaney D, Jimenez-Morales D, Johnson J, Garelis N, Repasy T Elife. 2020; 9.
PMID: 31951200 PMC: 7030789. DOI: 10.7554/eLife.51461.
A20 at the Crossroads of Cell Death, Inflammation, and Autoimmunity.
Martens A, van Loo G Cold Spring Harb Perspect Biol. 2019; 12(1).
PMID: 31427375 PMC: 6942121. DOI: 10.1101/cshperspect.a036418.
Interleukin-17 signaling triggers degradation of the constitutive NF-κB inhibitor ABIN-1.
Cruz J, Childs E, Amatya N, Garg A, Beyaert R, Kane L Immunohorizons. 2019; 1(7):133-141.
PMID: 30761389 PMC: 6370333. DOI: 10.4049/immunohorizons.1700035.
Yang Z, Zhong Z, Li M, Xiong Y, Wang Y, Peng G Int J Mol Med. 2016; 38(1):161-71.
PMID: 27177159 PMC: 4899006. DOI: 10.3892/ijmm.2016.2586.
Vanlangenakker N, Bertrand M, Bogaert P, Vandenabeele P, Vanden Berghe T Cell Death Dis. 2011; 2:e230.
PMID: 22089168 PMC: 3223695. DOI: 10.1038/cddis.2011.111.